Keratoprosthesis in dry eye disease

被引:3
|
作者
Sharma, Supriya [1 ]
Donthineni, Pragnya Rao [2 ]
Iyer, Geetha [3 ]
Chodosh, James [4 ]
de la Paz, Maria Fideliz [5 ]
Maskati, Quresh [6 ]
Srinivasan, Bhaskar [3 ]
Agarwal, Shweta [3 ]
Basu, Sayan [2 ,7 ,9 ]
Shanbhag, Swapna S. [2 ,8 ]
机构
[1] Shantilal Shanghvi Eye Inst, Cornea & Anterior Segment Serv, Mumbai, Maharashtra, India
[2] LV Prasad Eye Inst, Shantilal Shanghvi Cornea Inst, Hyderabad, Telangana, Pakistan
[3] Sankara Nethralaya, Med Res Fdn, CJ Shah Cornea Serv, Dr G Sitalakshmi Mem Clin Ocular Surface Disorders, Chennai, Tamil Nadu, India
[4] Univ New Mexico, Dept Ophthalmol & Visual Sci, Sch Med, Albuquerque, NM USA
[5] Oftalvist Barcelona, Barcelona, Spain
[6] Maskati Eye Clin, Mumbai, Maharashtra, India
[7] LV Prasad Eye Inst, Ctr Ocular Regenerat CORE, Prof Brien Holden Eye Res Ctr BHERC, Hyderabad, Telangana, Pakistan
[8] LV Prasad Eye Inst, Shantilal Shanghvi Cornea Inst, Hyderabad 500034, Telangana, India
[9] LV Prasad Eye Inst, Prof D Balasubramanian Chair Eye Res, Prof Brien Holden Eye Res Ctr BHERC, Hyderabad 500034, India
关键词
Chronic cicatrizing conjunctivitis; dry eye disease; keratoprosthesis; limbal stem cell deficiency; ocular chemical burns; mucous membrane pemphigoid; Stevens-Johnson syndrome; OSTEO-ODONTO-KERATOPROSTHESIS; LONG-TERM OUTCOMES; OCULAR SURFACE DISEASE; BOSTON KERATOPROSTHESIS; MICOF KERATOPROSTHESIS; VISUAL REHABILITATION; I KERATOPROSTHESIS; SURGICAL TECHNIQUE; END-STAGE; COMPLICATIONS;
D O I
10.4103/IJO.IJO_2817_22
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Bilateral corneal blindness with severe dry eye disease (DED), total limbal stem cell deficiency with underlying corneal stromal scarring and vascularization, combined with adnexal complications secondary to chronic cicatrizing conjunctivitis is a highly complex situation to treat. In such eyes, procedures such as penetrating keratoplasty alone or combined with limbal stem cell transplantation are doomed to fail. In these eyes, keratoprosthesis (Kpro) or an artificial cornea is the most viable option, eliminating corneal blindness even in eyes with autoimmune disorders such as Stevens-Johnson syndrome, ocular mucous membrane pemphigoid, Sjogren's syndrome, and nonautoimmune disorders such as chemical/thermal ocular burns, all of which are complex pathologies. Performing a Kpro in these eyes also eliminates the need for systemic immunosuppression and may provide relatively early visual recovery. In such eyes, the donor cornea around the central cylinder of the Kpro needs to be covered with a second layer of protection to avoid desiccation and progressive stromal melt of the underlying cornea, which is a common complication in eyes with severe DED. In this review, we will focus on Kpro designs that have been developed to survive in eyes with the hostile environment of severe DED. Their outcomes in such eyes will be discussed.
引用
收藏
页码:1154 / 1166
页数:13
相关论文
共 50 条
  • [31] Novel Eye Drops for the Treatment of Dry Eye Disease
    Lasowski, Frances
    Muirhead, Ben B.
    Hicks, Emily Anne
    Rambarran, Talena
    Liu, Lina
    Sheardown, Heather
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [32] Dry eye syndrome in patients with allergic eye disease
    Acuna Ortega, Natalhie
    Gonzalez Diaz, Sandra
    Mohamed Hamsho, Jesus
    Mohamed Noriega, Karim
    Macias Weinmann, Alejandra
    Guzm Avilan, Rosa
    Santos Fernandez, Wendy
    Murillo Rodriguez, Jose
    Pacheco Gonzalez, Rodrigo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB217 - AB217
  • [33] Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease
    Lee, Yonghoon
    Kim, Minji
    Galor, Anat
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2022, 105 (02) : 177 - 185
  • [34] Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren’s syndrome dry eye disease
    Brigitte Sloesen
    Alyson Young
    Katie Forde
    Nicola Hodson
    Sarah Bentley
    Oonagh Walsh
    Christel Naujoks
    Paul O’Brien
    Garima Sharma
    Journal of Patient-Reported Outcomes, 7
  • [35] Digital solutions for dry eye disease
    de Ribot, Francesc March
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [36] Dry Eye Disease An Update in 2022
    Hakim, Farida E.
    Farooq, Asim, V
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (05): : 478 - 479
  • [37] A new appreciation for dry eye disease
    Foulks, Gary N.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2009, 44 (04): : 370 - 371
  • [38] Dry Eye: A Protein Conformational Disease
    Azharuddin, Mohammad
    Khandelwal, Jayesh
    Datta, Himadri
    Dasgupta, Anjan Kr
    Raja, Sufi O.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (03) : 1423 - 1429
  • [39] Hot Topics in Dry Eye Disease
    Alberto Chiaradia, Pablo
    Zeman Bardeci, Luis Alberto
    Dankert, Sebastian
    Omar Mendaro, Marcos
    Grzybowski, Andrzej
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (04) : 608 - 623
  • [40] Advances in dry eye disease treatment
    O'Neil, Erin C.
    Henderson, Matthew
    Massaro-Giordano, Mina
    Bunya, Vatinee Y.
    CURRENT OPINION IN OPHTHALMOLOGY, 2019, 30 (03) : 166 - 178